http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000503579-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-0601
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
filingDate 1997-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2000-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2000503579-A
titleOfInvention Body light treatment of blood
abstract (57) Abstract: The present invention relates to a method for destroying or affecting an undesired component in blood that has absorbed a photoreactive agent having a characteristic light absorption band, thereby preventing blood flowing through the body of a patient from being absorbed into the body. The present invention relates to a method and an apparatus for applying optical pheresis. The device has an implantable housing (100) designed for percutaneous placement in a patient. An inlet (104) and an outlet (102) for a fluid passageway (128) through the housing (100) are provided and connected to the patient's circulatory system to introduce and drain blood into the housing (100). . A light source (110) located in the housing (100) (or externally connected to the housing by an optical fiber) emits light within a band substantially equal to the absorption band of the photoreactive agent. discharge. A portion of the fluid passage (128) in the housing (100) is optionally optically transparent so that blood is illuminated by light from the light source. The fluid passageway (128) can be of any of a variety of shapes, including coiled tubes, flat coils, helical coils, and cross tubes connecting the inlet and outlet header manifolds. The light source (110) includes a light emitting diode (LED) or other type of light source and can be connected to a photoreactor through an optical fiber. The power source (800) of the light source (110) can be internal or external.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017164202-A1
priorityDate 1996-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546216
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4114

Total number of triples: 16.